share_log

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.61%)

bluebird bio | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(4.61%)

SEC announcement ·  02/13 17:07
Moomoo AI 已提取核心信息
On December 29, 2023, The Vanguard Group filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of bluebird bio, Inc. common stock. The filing revealed that The Vanguard Group now beneficially owns 8,775,379 shares of bluebird bio, which represents 4.61% of the company's class of common stock. This position is a result of shared voting power over 49,185 shares and sole dispositive power over 8,670,555 shares, with an additional shared dispositive power over 104,824 shares. The Vanguard Group, headquartered in Pennsylvania, is an investment adviser and reports that the securities were acquired in the ordinary course of business, not with the purpose of changing or influencing the control of bluebird bio, Inc.
On December 29, 2023, The Vanguard Group filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of bluebird bio, Inc. common stock. The filing revealed that The Vanguard Group now beneficially owns 8,775,379 shares of bluebird bio, which represents 4.61% of the company's class of common stock. This position is a result of shared voting power over 49,185 shares and sole dispositive power over 8,670,555 shares, with an additional shared dispositive power over 104,824 shares. The Vanguard Group, headquartered in Pennsylvania, is an investment adviser and reports that the securities were acquired in the ordinary course of business, not with the purpose of changing or influencing the control of bluebird bio, Inc.
2023年12月29日,Vanguard集团向美国证券交易委员会提交了经修订的附表13G/A,表明其持有的蓝鸟生物公司普通股发生了变化。该文件显示,Vanguard集团现在实益拥有蓝鸟生物的8,775,379股股份,占该公司普通股类别的4.61%。这一立场是对49,185股的共同投票权和对8,670,555股股票的唯一处置权的结果,另外还有对104,824股股票的共同处置权。总部位于宾夕法尼亚州的Vanguard Group是一家投资顾问,该公司报告说,这些证券是在正常业务过程中收购的,其目的不是改变或影响蓝鸟生物公司的控制权。
2023年12月29日,Vanguard集团向美国证券交易委员会提交了经修订的附表13G/A,表明其持有的蓝鸟生物公司普通股发生了变化。该文件显示,Vanguard集团现在实益拥有蓝鸟生物的8,775,379股股份,占该公司普通股类别的4.61%。这一立场是对49,185股的共同投票权和对8,670,555股股票的唯一处置权的结果,另外还有对104,824股股票的共同处置权。总部位于宾夕法尼亚州的Vanguard Group是一家投资顾问,该公司报告说,这些证券是在正常业务过程中收购的,其目的不是改变或影响蓝鸟生物公司的控制权。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息